Does atorvastatin therapy change the anti‐Xa activity in xabans‐treated patients with atrial fibrillation?

• Main Authors: Ingrid Škorňová (Author), Matej Samoš (Author), Tomáš Bolek (Author), Lucia Stančiaková (Author), Ľubica Vádelová (Author), Peter Galajda (Author), Ján Staško (Author), Peter Kubisz (Author), Marián Mokáň (Author)
• Format: Book
• Published: Wiley, 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Atorvastatin and direct oral factor Xa inhibitors (xabans) are frequently co‐administrated in patients with atrial fibrillation (AF). However, no studies investigating the possibility of the pharmacologic interaction between these agents have been conducted. The aim of this prospective obse...